FDA inspection
Meribel Pharma Karlskoga AB: FDA inspection ending May 15, 2014
FDA inspection 878699 · No Action Indicated (NAI) · Karlskoga
Key facts
| Inspection ID | 878699 |
|---|---|
| Firm | Meribel Pharma Karlskoga AB |
| FEI number | 3004713444 |
| Address | Bjorkbornsvagen 5 |
| City | Karlskoga |
| Country | Sweden |
| Fiscal year | 2014 |
| Inspection end date | May 15, 2014 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data